Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

Proven Success for Treatment-Resistant Conditions Many individuals in NYC have turned to ketamine therapy ... These options ...

People suffering from major depressive disorder (MDD) and treatment-resistant depression (TRD) often face challenging ...

Autism is a complex interplay of symptoms that extend far beyond the diagnostic labels commonly associated with mental health conditions. From mood dysregulation and attentional challenges to trauma ...

A recent study published in the Journal of Psychopharmacology examined the effectiveness of psychedelic-assisted therapy on ...

Atai Life Sciences N.V. ( (ATAI) ) has released its Q3 earnings. Here is a breakdown of the information Atai Life Sciences N.V. presented to ...

By targeting complex conditions such as treatment-resistant depression, social anxiety disorder and opioid use disorder, Atai aims to address significant gaps in the mental health treatment landscape.

Psilocybin therapy -- used to treat a range of mental health conditions, such as depression, anxiety, and addictions -- can ...

A concerning increase in antibiotic-resistant infections has been reported across the UK. The UK Health Security Agency ...

Research suggests that CBD may help reduce the symptoms of certain types of anxiety. More recently, a 2022 trial looked at the effects of CBD on treatment-resistant anxiety in young adults.

In terms of anxiety symptoms, 54.5 % of patients exhibited such symptoms prior to CBD treatment, with 71 % showing improvement post-treatment. “Adjunctive CBD treatment in adult patients with ...

The United States Food and Drug Administration cleared the investigational new drug application for VLS-01 (buccal film DMT); atai expects to ...